These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 12085033)

  • 1. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Siqueira E; Schoen RE; Silverman W; Martin J; Rabinovitz M; Weissfeld JL; Abu-Elmaagd K; Madariaga JR; Slivka A
    Gastrointest Endosc; 2002 Jul; 56(1):40-7. PubMed ID: 12085033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
    Ramage JK; Donaghy A; Farrant JM; Iorns R; Williams R
    Gastroenterology; 1995 Mar; 108(3):865-9. PubMed ID: 7875490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CA19-9 does not predict cholangiocarcinoma in patients with primary sclerosing cholangitis undergoing liver transplantation.
    Fisher A; Theise ND; Min A; Mor E; Emre S; Pearl A; Schwartz ME; Miller CM; Sheiner PA
    Liver Transpl Surg; 1995 Mar; 1(2):94-8. PubMed ID: 9346547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis.
    Ahrendt SA; Pitt HA; Nakeeb A; Klein AS; Lillemoe KD; Kalloo AN; Cameron JL
    J Gastrointest Surg; 1999; 3(4):357-67; discussion 367-8. PubMed ID: 10482687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Wannhoff A; Hov JR; Folseraas T; Rupp C; Friedrich K; Anmarkrud JA; Weiss KH; Sauer P; Schirmacher P; Boberg KM; Stremmel W; Karlsen TH; Gotthardt DN
    J Hepatol; 2013 Dec; 59(6):1278-84. PubMed ID: 23958938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis Patients: Single Center Experience.
    Kuzu UB; Ödemiş B; Suna N; Yıldız H; Parlak E; Dişibeyaz S; Torun S; Akpınar MY; Coşkun O; Turhan N; Yüksel M; Kayaçetin E
    J Gastrointest Cancer; 2016 Mar; 47(1):8-14. PubMed ID: 26537791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biliary brush cytology and the detection of cholangiocarcinoma in primary sclerosing cholangitis: evaluation of specific cytomorphologic features and CA19-9 levels.
    Furmanczyk PS; Grieco VS; Agoff SN
    Am J Clin Pathol; 2005 Sep; 124(3):355-60. PubMed ID: 16191503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in the research on biomarkers of cholangiocarcinoma in primary sclerosing cholangitis.
    Wannhoff A; Gotthardt DN
    Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):236-243. PubMed ID: 30266579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristic Features of Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis.
    Ishii Y; Sasaki T; Serikawa M; Kobayashi K; Kamigaki M; Minami T; Okazaki A; Yukutake M; Ishigaki T; Kosaka K; Mouri T; Yoshimi S; Chayama K
    Hepatogastroenterology; 2014 May; 61(131):567-73. PubMed ID: 26176037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis.
    Charatcharoenwitthaya P; Enders FB; Halling KC; Lindor KD
    Hepatology; 2008 Oct; 48(4):1106-17. PubMed ID: 18785620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Hultcrantz R; Olsson R; Danielsson A; Järnerot G; Lööf L; Ryden BO; Wahren B; Broomé U
    J Hepatol; 1999 Apr; 30(4):669-73. PubMed ID: 10207809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.
    Patel AH; Harnois DM; Klee GG; LaRusso NF; Gores GJ
    Am J Gastroenterol; 2000 Jan; 95(1):204-7. PubMed ID: 10638584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma.
    Nakeeb A; Lipsett PA; Lillemoe KD; Fox-Talbot MK; Coleman J; Cameron JL; Pitt HA
    Am J Surg; 1996 Jan; 171(1):147-52; discussion 152-3. PubMed ID: 8554130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.
    Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
    Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Björnsson E; Kilander A; Olsson R
    Liver; 1999 Dec; 19(6):501-8. PubMed ID: 10661684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis.
    Lindberg B; Arnelo U; Bergquist A; Thörne A; Hjerpe A; Granqvist S; Hansson LO; Tribukait B; Persson B; Broomé U
    Endoscopy; 2002 Nov; 34(11):909-16. PubMed ID: 12430077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of a stepwise cytological algorithm for biliary malignancy in primary sclerosing cholangitis.
    von Seth E; Ouchterlony H; Dobra K; Hjerpe A; Arnelo U; Haas S; Bergquist A
    Liver Int; 2019 Feb; 39(2):382-388. PubMed ID: 30507030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosing cholangiocarcinoma in primary sclerosing cholangitis: an "evidence based radiology" review.
    Walker SL; McCormick PA
    Abdom Imaging; 2008; 33(1):14-7. PubMed ID: 17874262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.
    Boyd S; Vannas M; Jokelainen K; Isoniemi H; Mäkisalo H; Färkkilä MA; Arola J
    World J Gastroenterol; 2017 Sep; 23(33):6147-6154. PubMed ID: 28970730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary sclerosing cholangitis: patients with a rising alkaline phosphatase at annual follow-up.
    Charatcharoenwitthaya P; Lindor KD
    Clin Gastroenterol Hepatol; 2007 Jan; 5(1):32-6. PubMed ID: 17234554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.